Parkman Healthcare Partners LLC - ARCELLX INC ownership

ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 120 filers reported holding ARCELLX INC in Q1 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.9%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of ARCELLX INC
ValueSharesWeighting
Q3 2023$7,300,934
+18.3%
203,482
+4.2%
1.34%
+25.0%
Q2 2023$6,174,121
+35.7%
195,260
+32.2%
1.07%
+8.2%
Q1 2023$4,548,973
+21.3%
147,646
+21.9%
0.99%
-1.0%
Q4 2022$3,751,461
+42.9%
121,093
-13.4%
1.00%
+33.9%
Q3 2022$2,625,000
-18.4%
139,875
-21.4%
0.75%
-37.0%
Q2 2022$3,218,000178,0001.18%
Other shareholders
ARCELLX INC shareholders Q1 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,500,007$169,455,21663.12%
NEA Management Company, LLC 4,745,262$146,201,52210.11%
Samsara BioCapital, LLC 909,579$28,024,1295.79%
Paradigm Biocapital Advisors LP 1,757,779$54,157,1715.13%
Soleus Capital Management, L.P. 1,248,147$38,455,4093.98%
Perceptive Advisors 3,841,739$118,363,9793.50%
Cormorant Asset Management, LP 1,600,000$49,2963.25%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,398,321$73,892,2703.12%
Altium Capital Management LP 150,000$4,621,5002.56%
Novo Holdings A/S 1,225,000$37,742,2502.49%
View complete list of ARCELLX INC shareholders